| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.13 | 0.01 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.1 | 0.02 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.092 | 0.03 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.083 | 0.08 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.065 | 0.1 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.066 | 0.1 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.061 | 0.2 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.059 | 0.2 |